Wakix (pitolisant) - Medicaid

Prior Authorization, Quantity Limit

Opioid Concurrent Opioid Dependence Therapy - Medicaid

Prior Authorization

Hereditary Angioedema - Commercial

Prior Authorization, Quantity Limit

Continuous Glucose Monitor (CGM) - Medicaid

Quantity Limit

QP22-21 Commercial and MHCP Pharmacy Benefit Exclusion for Nulibry™

QP23-21 Cellular and Gene Therapy Product Reimbursement Policy Update

Employer ICHRA Attestation

QSHERA

Third Party Payer Form with Employer forms

BCBSMN-Pharmacy-Prog-Policy-Notif_050121.pdf